Bhupinder Singh, MD, FASN, FNKF, is a nephrologist and clinical professor. He serves as an adjunct Clinical Professor of Medicine at the University of California, Irvine School of Medicine and is the co‑founder, chief medical officer, and a board director at Renibus Therapeutics. Clinically, he focuses on acute and chronic kidney care, renal replacement therapies, and electrolyte and fluid balance. His research centers on cardiorenal therapeutics, electrolyte and fluid regulation, and translational drug development in nephrology. He has served as principal investigator in more than 50 clinical trials, with work published in leading journals including the New England Journal of Medicine and JAMA. A recognized leader across academia and industry, Dr. Singh has held senior roles guiding clinical development and medical affairs, including vice president at Allakos and executive director at ZS Pharma, and he founded Southwest Kidney Institute and Nephcentric. Dr. Singh earned his medical degree from the Armed Forces Medical College in India and completed postgraduate training at Henry Ford Health System and SUNY Upstate Medical University.
Professor
Medical School
Fellowship
2000 – 2002